ViroFend Therapeutics Email Formats
Biotechnology Research • • 11-20 Employees
ViroFend Therapeutics Email Formats
ViroFend Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@virofend.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@virofend.com | 80% |
{first initial}.{second initial} | j.o@virofend.com | 20% |
Key Contacts at ViroFend Therapeutics
Sara Cuadrado Castaño
Co-Founder Cso
Ángel Canal Alonso
Director Of Operations And R&D
Leandro Machineña
Director De Desarrollo Estratégico
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 11-20 |
About ViroFend Therapeutics
At Virofend SL, we develop virus-based therapies, specifically targeting cancer. Viral treatments represent one of the most innovative and promising areas in modern medicine, leveraging the unique properties of viruses, such as their ability to infect specific cells and trigger immune responses. Genetically modified viruses are used to attack and destroy cancer cells. These approaches not only offer new hope for difficult-to-treat diseases but also open the door to an era of personalized and highly effective treatments.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
ViroFend Therapeutics has 7 employees across 3 departments.
Departments
Number of employees
Funding Data
ViroFend Therapeutics has never raised funding before.
ViroFend Therapeutics Tech Stack
Discover the technologies and tools that power ViroFend Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Performance
Hosting
United Kingdom
Australia
Frequently asked questions
4.8
40,000 users
